These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 22617649)
1. Aspartoacylase supports oxidative energy metabolism during myelination. Francis JS; Strande L; Markov V; Leone P J Cereb Blood Flow Metab; 2012 Sep; 32(9):1725-36. PubMed ID: 22617649 [TBL] [Abstract][Full Text] [Related]
2. N-acetylaspartate supports the energetic demands of developmental myelination via oligodendroglial aspartoacylase. Francis JS; Wojtas I; Markov V; Gray SJ; McCown TJ; Samulski RJ; Bilaniuk LT; Wang DJ; De Vivo DC; Janson CG; Leone P Neurobiol Dis; 2016 Dec; 96():323-334. PubMed ID: 27717881 [TBL] [Abstract][Full Text] [Related]
3. Uncoupling N-acetylaspartate from brain pathology: implications for Canavan disease gene therapy. von Jonquieres G; Spencer ZHT; Rowlands BD; Klugmann CB; Bongers A; Harasta AE; Parley KE; Cederholm J; Teahan O; Pickford R; Delerue F; Ittner LM; Fröhlich D; McLean CA; Don AS; Schneider M; Housley GD; Rae CD; Klugmann M Acta Neuropathol; 2018 Jan; 135(1):95-113. PubMed ID: 29116375 [TBL] [Abstract][Full Text] [Related]
4. Restoration of aspartoacylase activity in CNS neurons does not ameliorate motor deficits and demyelination in a model of Canavan disease. Klugmann M; Leichtlein CB; Symes CW; Serikawa T; Young D; During MJ Mol Ther; 2005 May; 11(5):745-53. PubMed ID: 15851013 [TBL] [Abstract][Full Text] [Related]
5. N-Acetylaspartate Synthase Deficiency Corrects the Myelin Phenotype in a Canavan Disease Mouse Model But Does Not Affect Survival Time. Maier H; Wang-Eckhardt L; Hartmann D; Gieselmann V; Eckhardt M J Neurosci; 2015 Oct; 35(43):14501-16. PubMed ID: 26511242 [TBL] [Abstract][Full Text] [Related]
6. Dietary triheptanoin rescues oligodendrocyte loss, dysmyelination and motor function in the nur7 mouse model of Canavan disease. Francis JS; Markov V; Leone P J Inherit Metab Dis; 2014 May; 37(3):369-81. PubMed ID: 24288037 [TBL] [Abstract][Full Text] [Related]
12. Renewal of oligodendrocyte lineage reverses dysmyelination and CNS neurodegeneration through corrected N-acetylaspartate metabolism. Lotun A; Li D; Xu H; Su Q; Tuncer S; Sanmiguel J; Mooney M; Baer CE; Ulbrich R; Eyles SJ; Strittmatter L; Hayward LJ; Gessler DJ; Gao G Prog Neurobiol; 2023 Jul; 226():102460. PubMed ID: 37149081 [TBL] [Abstract][Full Text] [Related]
13. Redirecting Gessler DJ; Li D; Xu H; Su Q; Sanmiguel J; Tuncer S; Moore C; King J; Matalon R; Gao G JCI Insight; 2017 Feb; 2(3):e90807. PubMed ID: 28194442 [TBL] [Abstract][Full Text] [Related]
14. Are astrocytes the missing link between lack of brain aspartoacylase activity and the spongiform leukodystrophy in Canavan disease? Baslow MH; Guilfoyle DN Neurochem Res; 2009 Sep; 34(9):1523-34. PubMed ID: 19319678 [TBL] [Abstract][Full Text] [Related]
16. N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology. Moffett JR; Ross B; Arun P; Madhavarao CN; Namboodiri AM Prog Neurobiol; 2007 Feb; 81(2):89-131. PubMed ID: 17275978 [TBL] [Abstract][Full Text] [Related]
17. Canavan disease. Analysis of the nature of the metabolic lesions responsible for development of the observed clinical symptoms. Baslow MH; Resnik TR J Mol Neurosci; 1997 Oct; 9(2):109-25. PubMed ID: 9407392 [TBL] [Abstract][Full Text] [Related]
18. Nur7 is a nonsense mutation in the mouse aspartoacylase gene that causes spongy degeneration of the CNS. Traka M; Wollmann RL; Cerda SR; Dugas J; Barres BA; Popko B J Neurosci; 2008 Nov; 28(45):11537-49. PubMed ID: 18987190 [TBL] [Abstract][Full Text] [Related]
19. Intracerebroventricular administration of N-acetylaspartic acid impairs antioxidant defenses and promotes protein oxidation in cerebral cortex of rats. Pederzolli CD; Rockenbach FJ; Zanin FR; Henn NT; Romagna EC; Sgaravatti AM; Wyse AT; Wannmacher CM; Wajner M; de Mattos Dutra A; Dutra-Filho CS Metab Brain Dis; 2009 Jun; 24(2):283-98. PubMed ID: 19294497 [TBL] [Abstract][Full Text] [Related]